Zomedica Announces Record Third Quarter 2023 Financial Results: Revenue up 31% to $6.3 Million; 69% Gross Margin, and $118 Million in Liquidity, while Making Strategic Acquisitions of Structured Monitoring Products and Qorvo Biotechnologies

ANN ARBOR, MI / ACCESSWIRE / November 13, 2023 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostics and therapeutic products for companion

Related Keywords

United States ,Ann Arbor ,Michigan ,American ,Larry Heaton ,Qorvo Biotechnologies ,Exchange Commission On ,Pathology Department ,Monitoring Products Inc ,Zomedica Corp ,Quarter Financial ,Therapeutic Devices ,Structured Monitoring ,Structured Monitoring Products ,Current Report ,Exchange Commission ,Company Guide ,Quarter Results ,Chief Financial Officer ,Revo Squared ,Outstanding Share ,Call Details ,Results Conference ,Relations Contact ,Three Months ,Region ,